Glycans are modifications to proteins that can be detected and sequenced to tell us about the pathology of different organs.

These changes are especially prevalent in cancers. Using our proprietary GlycoSeq technology, we detect cancer-associated changes in glycosylation, providing sensitive and accurate discrimination between benign hyperplasias and potentially deadly cancers.

Contact us to learn more or get involved!